DUBLIN, July 26, 2022 /PRNewswire/ — The “Global Smart Pills Market Report 2022” report has been added to ResearchAndMarkets.com’s offering.
The global smart pills market is expected to grow from $4.03 billion in 2021 to $4.48 billion in 2022 at a compound annual growth rate (CAGR) of 11.2%. The market is expected to grow to $6.83 billion in 2026 at a compound annual growth rate (CAGR) of 11.1%.
The smart pills market consists of the sales of capsule-sized ingestible medical devices with small embedded electronic products such as sensors, cameras, patches, and trackers. Once swallowed, the smart pill gets activated in the gut and the sensors provide information about the patient’s health parameters and the effectiveness of medication leading to more optimized therapies.
The main applications of smart pills are capsule endoscopy, patient monitoring, and drug delivery, patient monitoring involves the repeated or continuous observations or measurements of the patient parameters. These pills are used to target the esophagus, stomach, small intestine, and large intestine to treat diseases such as esophageal diseases, colon diseases, small bowel diseases, and others. Smart pills are used by various end-users such as hospitals, diagnostic centers, and research institutes.
The growing preference for non-invasive procedures is driving the smart pills market. For instance, smart pills have key applications in diagnostic imaging such as capsule endoscopy. The capsule endoscopy is a diagnostic procedure in which a smart pill (capsule enclosed micro-camera) is swallowed and images of the esophagus, stomach, and small intestine can be taken as the device pass through your gastrointestinal (GI) tract.
Smart pills have revolutionized the diagnosis of gastrointestinal disorders and could replace conventional diagnostic techniques such as endoscopy. Therefore, non-invasive procedures are driving the smart pills market during the …